featured
Safety and Efficacy of Mesenchymal Stromal Cells in Treating ARDS in Patients With COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
American Journal of Respiratory and Critical Care Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical Trial
Am J Respir Crit Care Med 2023 Aug 01;208(3)256-269, EA Gorman, J Rynne, HJ Gardiner, AJ Rostron, J Bannard-Smith, AM Bentley, D Brealey, C Campbell, G Curley, M Clarke, A Dushianthan, P Hopkins, C Jackson, K Kefela, A Krasnodembskaya, JG Laffey, C McDowell, M McFarland, J McFerran, P McGuigan, GD Perkins, J Silversides, J Smythe, J Thompson, WS Tunnicliffe, IDM Welters, L Amado-Rodríguez, G Albaiceta, B Williams, M Shankar-Hari, DF McAuley, CM O'KaneFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.